Patent appeal board takes up Ozempic challenge
The US Patent and Trademark Office’s Patent Trial and Appeal Board has agreed to take another look at a patent covering certain strengths of Novo …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
